NCT01014156View on ClinicalTrials.gov

Epoprostenol in Pulmonary Embolism

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Acute Pulmonary Embolism
Interventions
DRUG

epoprostenol

titration up to 4 ng/kg/min

Trial Locations (1)

1081 HV

Free University Medical Center, Amsterdam

All Listed Sponsors
lead

Free University Medical Center

OTHER

NCT01014156 - Epoprostenol in Pulmonary Embolism | Biotech Hunter | Biotech Hunter